Process for preparing optically active 3-hydroxypyrrolidine derivatives

Abstract: A process for preparing an optically active 3-hydroxypyrrolidine derivative: wherein Q represents an optionally substituted phenyl group; and * indicates an asymmetric carbon atom, comprises reacting 1 mole of an optically active 4-halo-3-hydroxybutane derivative: wherein R¹ represents a lower alkyl group a phenyl group which may be substituted with lower alkyl or alkoxy or halogen; and X represents a halogen atom, dissolved in an alcohol, with 1 to 2 moles of a benzylamine or a derivative thereof (II): H₂NCH₂Q and heating the mixture of reflux for 5 to 20 hours. Preparation of starting material (I) is described. The exemplified yields are 37-97 wt %: The starting compound (I) is easily available by a simple chemical synthesis, without use of any expensive reagent.

Description: This invention relates to a process for preparing optically active 3-hydroxypyrrolidine derivatives represented by formula (III) shown below which are useful as intermediates for synthesizing pharmaceuticals: wherein Q represents a substituted or unsubstituted phenyl group; and * indicates an asymmetric carbon atom. Optically active 1-benzyl-3-hydroxypyrrolidine or a derivative thereof represented by formula (III) is used to form 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid-3-(1-benzyl-3-pyrrolidinyl) ester-5-methyl ester (hereinafter referred to as YM-09730), which has recently been found to have characteristic pharmacological effects, such as an effect of increasing coronary blood flow when it is directly administered into the coronary artery. Thus, the compounds of formula (III) have been used as starting materials for pharmaceuticals (see JP-A-61-63652 (the term "JP-A" as used herein means an unexamined published Japanese patent application )). 3-Hydroxypyrrolidine,which is structurally similar to the optically active 3-hydroxypyrrolidine derivatives of formula (III), is an industrially useful compound known for years as an intermediate for pharmaceuticals and agricultural chemicals. It has conventionally been synthesized by, for example, obtaining 1-benzyl-3-hydroxypyrrolidine and heating it in an autoclave in a hydrogen gas atmosphere in the presence of a palladium catalyst to release toluene. Other known processes for preparing 3-hydroxypyrrolidine include a process comprising reaction of 4-amino-1,2-butanediol in the presence of a metallic catalyst (see JP-A-57-56457), a process comprising decarboxylation of 4-hydroxy-L-proline in the presence of cyclohexenone (see JP-A-60-23328), and a process comprising reacting a butane derivative represented by formula: wherein X¹ and X², which may be the same or different, each represents an alkylsulfonyloxy group, a halogenoalkylsulfonyloxy group, an arylsulfonyloxy group or a halogen atom, e.g., 2-hydroxy-1,4-di(methylsulfonyloxy)butane, with ammonia (see JP-A-60-104061). Processes for synthesizing 1-benzyl-3-hydroxypyrrolidine, one of the compounds made by the present invention, which have been proposed to date include (1) a process comprising cyclizing dℓ-malic acid by reacting with benzylamine to obtain 1-benzyl-3-hydroxysuccinic acid imide, which is then reduced with lithium aluminum hydride as described in Synthetic Communications , Vol. 13 (13), pp. 1117-1123 (1983); and (2) a process comprising reacting an alkyl 4-halo-3-h-hydroxybutyrate or an alkyl 3,4-epoxybutyrate with a benzylamine derivative to obtain a 1-benzyl-4-hydroxy-2-pyrrolidone derivative, which is then reduced with a reducing agent, e.g., lithium aluminum hydride, as described in JP-A-64-45360 and JP-A-1-207266. From the fact that YM-09730 obtained via optically active (S)-(-)-1-benzyl-3-hydroxypyrrolidine as an intermediate is pharmacologically useful, a process for preparing (S)-(-)-1-benzyl-3-hydroxypyrrolidine has been proposed, in which optically active mandelic acid is added to a mixture of (S)-(-)-1-benzyl-3-hydroxypyrrolidine and a small proportion of by-produced (R)-(+)-1-benzyl-3-hydroxypyrrolidine which is obtained from (S)-(-)-malic acid according to the above-described process (1), to thereby crystallize a mandelic acid salt of (S)-(-)-1-benzyl-3-hydroxypyrrolidine, and the acid radical is then removed with an alkali, as disclosed in JP-A-61-63652. However, each of the conventional processes for obtaining optically active 1-benzyl-3-hydroxypyrrolidine useful as an intermediate for pharmaceuticals involves problems. For example, naturally-occurring optically active compounds which are not easily available are used as a starting material in the process (1); a step of cyclization followed by reduction is required, and lithium aluminum hydride which is not only difficult to handle on an industrial scale but expensive must be used as a reducing agent in both processes (1) and (2). In the light of these problems, there is a need to develop an economically advantageous process for obtaining optically active 1-benzyl-3-hydroxypyrrolidine derivatives useful as intermediates for pharmaceuticals, which process starts with an easily available optically active compound obtainable through, for example, synthetic procedures, and requires no complicated step. The inventors have conducted extensive studies to solve the above-mentioned problems associated with conventional processes for preparing optically active 1-benzyl-3-hydroxypyrrolidine derivatives and, as a result, found that the desired compounds can be obtained with industrial advantages by cyclizing an optically active 4-halo-3-hydroxybutane derivative represented by formula (I) shown below by reaction with a benzylamine derivative and that the starting compound of formula (I) can be obtained by reducing an optically active 4-halo-3-hydroxybutyric hydroxybutyric acid ester, which is easily available through chemical synthesis in accordance with the process disclosed in JP-A-63-310847 (corresponding to U.S. Patent 4,933,482 and European Patent 295,109A) by part of the present inventors, and introducing a sulfonyl group, and thus completed the present invention. The present invention relates to a process of preparing an optically active 3-hydroxypyrrolidine derivative represented by the formula (III): wherein Q represents a phenyl group, which may be substituted with a Cl-4 alkyl group, a Cl-4 alkoxy group or a halogen atom; and * indicates an asymmetric carbon atoms, comprising reacting an optically active 4-halo-3-hydroxybutane derivative represented by the formula (I): wherein * is as defined above; R¹ represents a straight chain or branched alkyl group having from 1 to 4 carbon atoms, or is as defined for Q; and X represents a halogen atom, with a benzylamine derivative represented by formula (II): H₂NCH₂Q (II) wherein Q is as defined above. The starting optically active 4-halo-3-hydroxybutane derivative of formula (I), though not restricted as the process of preparation thereof, is advantageously obtained through chemical synthesis according to the following reaction scheme: wherein R¹, X and * are as defined above; and R² represents a straight chain or branched alkyl group having from 1 to 4 carbon atoms. The straight chain or branched alkyl group having from 1 to 4 carbon atoms represented by R² in formula (VI) includes, e.g., a methyl group, an ethyl group, an n-butyl group or an isobutyl group. The halogen atom represented by X includes a chlorine atom, a bromine atom and an iodine atom. The compound of formula (VI) can easily be obtained according to the process disclosed in JP-A-63-310847 supra , i.e., by asymmetrically hydrogenating a γ-halo-β-keto ester represented by formula (VII): wherein R² and X are as defined above, in the presence of a ruthenium-optically active phosphine complex as a catalyst. The thus obtained compound of formula (VI) is reduced to obtain an optically active 4-halo-1,3-butanediol of formula (IV). Methods for reducing a carboxylic acid ester to a corresponding alcohol include, for example, the process described in R.B. Moffett, Organic Synthesis , Collective volume 4, pp. 834-835 (1963) and the process described in R. Adams et al., Journal of American Chemical Society , Volume 72, pp. 158-163 (1950). Useful reducing agents include calcium borohydride and lithium aluminum hydride, with the former being preferred from the standpoint of reaction efficiency and economy. Calcium borohydride is easily obtained by reaction between 2 equivalents of sodium borohydride and 1 equivalent of calcium chloride. This reaction is preferably carried out in a water-free condition. That is, sodium borohydride and anhydrous calcium chloride are reacted in a solvent, e.g., dried dioxane, and the compound of formula (VI) is then added thereto dropwise at -10 to 30°C, and preferably 0 to 20°C, to conduct reduction reaction. After completion of the reaction, the reaction mixture is rendered acidic (pH 1 to 3) with an acid, e.g.,, a 10% hydrochloric acid solution in absolute methanol. The thus precipitated crystal is collected by filtration, freed of excess dioxane and methanol by distillation under reduced pressure at 40°C or lower, washed with a saturated sodium chloride aqueous solution, etc., and extracted with an appropriate solvent, e.g., ethyl acetate, to recover the compound of formula (IV). The compound of formula (IV) is then reacted with a sulfonyl compound represented by formula (V) to introduce an alkylsulfonyloxy group or an arylsulfonyloxy group selectively to the 1-positioned hydroxyl group of the compound of formula (IV) to thereby obtain an optically active compound of formula (I). The straight chain or branched alkyl group having from 1 to 4 carbon atoms represented by R¹ in formulae (I) and (V) includes, e.g., a methyl group or an isobutyl group. Selective substitution of the hydroxyl group at the 1-position of 1,3-butanediol can be effected, for example, by the process disclosed in Y. Gao et al., Journal of Organic Chemistry , Vol. 53, pp. 4081-4084 (1988). That is, the compound of formula (IV) is dissolved in an organic solvent, e.g., methylene chloride, dichloroethane, diethyl ether, dioxane or pyridine. After cooling the solution to -30° to 10°C, a base, e.g., triethylamine, dimethylaniline, pyridine or 4-dimethylaminopyridine, is added to the solution in an amount of from 2 to 10 mole, and preferably from 2 to 3 mole, per mole of the compound of formula (IV). Then, the sulfonyl compound of formula (V) is added thereto in an amount of from 1 to 1.2 mole per mole of the compound of formula (IV), and the mixture is allowed to react with stirring under temperature and time conditions selected according to the reaction rate of the compound (IV). After completion of the reaction, the reaction mixture is made acidic (pH 1 to 2) with an acid, e.g., a 5% hydrochloric acid aqueous solution, washed e.g. with a saturated sodium hydrogen carbonate aqueous solution or saturated sodium chloride aqueous solution, and freed of the excess solvent by distillation to obtain the compound of formula (I). The resulting compound of formula (I) is dissolved in an alcohol, e.g., methanol, ethanol or butanol, and to the solution is added an inorganic base, e.g., potassium carbonate, sodium carbonate or lithium carbonate, in an approximately equimolar amount to the compound (I) or an organic base, e.g., triethylamine, pyridine or dimethylaniline, preferably in an amount of from an equimolar amount to twice the molar amount of the compound (II). Then, the benzylamine derivative represented by formula (II) is added thereto preferably in an amount of from 1 to 2 mole, and most preferably from 1.1 to 1.2 mole, per mole of the compound (I), followed by heating at reflux for 5 to 20 hours. Examples of particularly preferred benzylamine derivatives represented by formula (II) are benzylamine, p-methoxybenzylamine, 2,4-dimethoxybenzylamine and 3,4,5-trimethoxybenzylamine. After completion of the reaction, the excess solvent is removed from the reaction mixture by distillation. The residue is subjected to liquid separation by using a solvent, e.g., a mixture of water and ethyl acetate, and the resulting organic layer is further worked up by, for example, distillation, to obtain the desired optically active 3-hydroxypyrrolidine derivative of formula (III). The present invention is now illustrated in greater detail by the following Examples, wherein percentages are by weight unless otherwise specified. In Examples, ¹H-NMR spectra were determined with a AM-400 spectrometer (400 MHz) manufactured by Bruker Inc. (internal standard: tetramethylsilane), and optical rotations were measured with a DIP-4 manufactured by JASCO Inc. EXAMPLE 1 Preparation of (3S)-4-Chloro-1,3-butanediol (IV) In 100 ml of dried 1,4-dioxane, 148.8 g (3.93 mole) of sodium borohydride and 218.3 g (1.93 mole) of anhydrous calcium chloride were reacted at room temperature for 15 hours. To the resulting calcium borohydride was added dropwise a mixed solution of 200 g (1.3 mole) of methyl (3S)-4-chloro-3-hydroxybutyrate and 200 ml of 1,4-dioxane at 15°C over a period of 4 hours. The mixture was stirred at 15°C for 15 hours, and 502 g (15.7 mole) of methanol was added dropwise thereto at that temperature over 4 hours. To the reaction mixture was added 2500 ml of a 10% hydrochloric acid solution in methanol at 20°C, and the precipitated crystal was removed by filtration. The filtrate was concentrated at 40°C under reduced pressure (5 to 10 mmHg). To the concentrate was added dropwise 870 ml of a saturated sodium chloride aqueous solution, and the precipitated crystal was removed by filtration. The filtrate was extracted three times with 3000 mℓ portions of ethyl acetate, and the extract was dried over anhydrous magnesium sulfate and concentrated under reduced pressure at 40°C to obtain 160 g (yield: 97%) of the titled compound. ¹H-NMR (CDCℓ₃) δ ppm: 1.75-1.85 (m, 2H), 3.58 (dd, 2H), 3.86 (m, 2H), 4.07 (m, 1H) EXAMPLE 2 Preparation of (3S)-4-Chloro-3-hydroxy-1-methylsulfonyloxybutane (I) A solution of 5 g (40 mmole) of (3S)-4-chloro-1,3-butanediol as obtained in Example 1 in 50 mℓ of methylene chloride was cooled to -30°C on a dry ice-acetone bath, and 11 mℓ (80 mmole) of triethylamine was added dropwise to the solution over 20 minutes. A solution of 4.58 g (40 mmole) of methanesulfonyl chloride in 100 mℓ of methylene chloride was then added dropwise thereto over 1 hour, followed by stirring for 30 minutes. The resulting reaction mixture was poured into 200 mℓ of ice-water to cause liquid separation. The organic layer was washed successively with 150 mℓ of 1N hydrochloric acid, 200 mℓ of a saturated sodium hydrogen carbonate aqueous solution, and 200 mℓ of a saturated sodium chloride aqueous solution, dried over anhydrous magnesium sulfate, and then freed of the solvent by distillation to obtain 3.10 g of a concentrate. ¹H-NMR determination revealed that the resulting concentrate contained 87.8% (yield: 36.8%) of desired (3S)-4-chloro-3-hydroxy-1-methylsulfonyloxybutane. ¹H-NMR (CDCℓ₃) δ ppm: 1.90-2.10 (m, 2H), 3.05 (s, 3H), 3.60 (m, 2H), 3.90 (m, 2H), 4.45 (m, 1H) EXAMPLE 3 Preparation of (3R)-4-Chloro-3-hydroxy-1-p-tolylsulfonyloxybutane (I) A solution of 5 g (40 mmole) of (3R)-4-chloro-1,3-butanediol in 30 mℓ of methylene chloride, said (3R)-4-chloro-1,3-butanediol being obtainable in a similar manner as in Example 1 starting from methyl (3R)-4-chloro-3-hydroxybutyrate, was cooled to -20°C on a dry ice-acetone bath, and 8.13 g (80 mmole) of triethylamine was added dropwise thereto over 30 minutes. A solution of 7.66 g (40.2 mmole) of p-toluenesulfonyl chloride in 100 mℓ of methylene chloride was added dropwise thereto over 50 minutes. After returning to room temperature, the mixture was stirred for 20 hours. The reaction mixture was poured into 200 mℓ of ice-water for liquid separation. The organic layer was washed successively with 100 mℓ of 1N hydrochloric acid, 100 mℓ x 2 of a saturated sodium hydrogen carbonate aqueous solution and 100 mℓ of a saturated sodium chloride aqueous solution and then freed of the solvent by distillation to obtain 7.8 g of a concentrate. The concentrate was purified by silica gel column chromatography (hexane/ethyl acetate = 2:1 by volume) to obtain 6.1 g (yield: 54%) of the titled compound. ¹H-NMR (CDCℓ₃) δ ppm: 1.78-2.00 (m, 2H), 2.46 (s, 3H), 3.45-3.65 (dd, 2H), 3.95 (m, 1H), 4.20 (m, 2H), 7.40 (d, 2H), 7.80 (d, 2H) EXAMPLE 4 Preparation of (3S)-4-Chloro-3-hydroxy-1-methylsulfonyloxybutane (I) A solution of 5 g (40 mmole) of (3S)-4-chloro-1,3-butanediol as obtained in Example 1 in 50 mℓ of methylene chloride was cooled to -30°C on a dry ice-acetone bath, and 9.48 g (80 mmole) of pyridine was added dropwise to the solution over 30 minutes. To the solution was added dropwise a solution of 4.58 g (40 mmole) of methanesulfonyl chloride in 50 mℓ of methylene chloride over 1 hour, followed by stirring at room temperature for 15 hours. The resulting reaction mixture was poured into 150 mℓ of ice-water for liquid separation. The organic layer was washed successively with 150 mℓ of 1N hydrochloric acid, 100 mℓ of a saturated sodium hydrogen carbonate aqueous solution, and 100 mℓ x 2 of a saturated sodium chloride aqueous solution, and dried over anhydrous magnesium sulfate. The solvent was removed by distillation to obtain 3.21 g (yield: 37.2%) of a concentrate. EXAMPLE 5 Preparation of (3S)-4-Chloro-3-hydroxy-1-methylsulfonyloxybutane (I) To a solution of 5 g (40 mmole) of (3S)-4-chloro-1,3-butanediol as obtained in Example 1 in 50 mℓ of dioxane was added dropwise 6.4 mℓ (80 mmole) of pyridine under ice-cooling (0-5°C) over 30 minutes. A solution of 4.58 g (40 mmole) of methanesulfonyl chloride in 50 mℓ of dioxane was then added dropwise thereto over 1 hour, followed by stirring at room temperature for 15 hours. The reaction mixture was poured into 150 mℓ of ice-water for liquid separation. The organic layer was washed successively with 150 mℓ of 1N hydrochloric acid, 100 mℓ of a saturated sodium hydrogen carbonate aqueous solution, and 100 mℓ x 2 of a saturated sodium chloride aqueous solution, dried over anhydrous magnesium sulfate, and freed of the solvent by distillation to obtain 6.5 g of a concentrate. ¹H-NMR determination revealed that the concentrate contained 92% of the titled compound (yield: 78%). EXAMPLE 6 Preparation of (3S)-1-Benzyl-3-hydroxypyrrolidine (III) To 2 g (10.6 mmole) of (3S)-4-chloro-3-hydroxy-1-methyl-sulfonyloxybutane as obtained in Example 4 were added 1.18 mℓ (10.7 mmole) of benzylamine, 1.34 g (12.72 mmole) of sodium carbonate, and 20 mℓ of ethanol, and the mixture was allowed to react at reflux for 5 hours. After cooling, the ethanol was removed by distillation under reduced pressure, and to the residue were added 20 mℓ of ethyl acetate and 10 mℓ of water, followed by stirring. After liquid separation, the organic layer was dried over anhydrous magnesium sulfate and the ethyl acetate was removed by distillation. The residue was distilled to obtain 1.76 g (yield: 94%) of the titled compound as a fraction having a boiling point of 105-110°C (0.9 mmHg). ¹H-NMR (CDCℓ₃) δ ppm: 1.75 (m, 1H), 2.20 (m, 1H), 2.35 (m, 1H), 2.50 (br, 1H), 2.60 (m, 1H), 2.70 (m, 1H), 2.90 (m, 1H), 3.70 (s, 2H), 4.32 (m, 1H), 7.30 (s, 2H) [α] 25 / D : -3.58° (c=5, methanol) The optical purity of the product was found to be 95.2 %ee as calculated from the data [α] 25 / D : -3.77° for 100 %ee in Bhat. K.L. et al., Synthetic Communications , Vol. 15, p. 587 (1985). EXAMPLE 7 Preparation of (3R)-1-Benzyl-3-hydroxypyrrolidine (III) To 2 g (7.18 mmole) of (3R)-4-chloro-3-hydroxy-1-p-tolyl-sulfonyloxybutane as obtained in Example 3 were added 0.78 g (7.3 mmole) of benzylamine, 0.92 g (8.68 mmole) of sodium carbonate, and 20 mℓ of ethanol, and the mixture was allowed to react at reflux for 7 hours. After cooling, ethanol was removed by distillation under reduced pressure. To the residue were added 100 mℓ of ethyl acetate and 50 mℓ of water, followed by stirring. After liquid separation, the organic layer was dried over anhydrous magnesium sulfate, and the solvent was removed by distillation. The residue was distilled under reduced pressure to obtain 1.1 g (yield: 86.5%) of the titled compound. As described above, the present invention provides a process for advantageously obtaining optically active 3-hydroxypyrrolidine derivatives useful as intermediates for synthesizing pharmaceuticals, characterized in that an optically active 4-halo-3-hydroxybutane derivative which can be easily synthesized is cyclized by a benzylamine derivative. As involving no complicated procedures as in conventional processes and also being economically advantageous, the process of the invention is industrially excellent.

Claims: A process of preparing an optically active 3-hydroxypyrrolidine derivative represented by the formula (III): wherein Q represents a phenyl group, which may be substituted with a Cl-4 alkyl group, a C1-4 alkoxy group or a halogen atom; and * indicates an asymmetric carbon atom, comprising reacting an optically active 4-halo-3-hydroxybutane derivative represented by the formula (I) wherein * is as defined above; R¹ represents a straight chain or branched alkyl group having from 1 to 4 carbon atoms, or is as defined for Q; and X represents a halogen atom, with a benzylamine derivative represented by the formula (II), by heating the reactants at reflux in an alcohol solvent in the presence of an inorganic base or an organic base: H₂NCH₂Q (II) wherein Q is as defined above. A process of preparing an optically active 3-hydroxypyrrolidine derivative as claimed in Claim 1, wherein the starting material (I) is prepared by reacting an optically active 4-halo-1,3-butanediol represented by the formula (IV): wherein * is as defined above, and X represents a halogen atom, with a sulfonyl compound represented by the formula (V): R¹SO₂Cℓ (V) wherein R¹ is as defined in Claim 1, to obtain said optically active 4-halo-3-hydroxybutane derivative represented by the formula (I). A process as claimed in Claim 2, wherein said butanediol (IV) is prepared by reducing an optically active 4-halo-3-hydroxybutyric acid ester represented by formula (VI): wherein * is as defined above; R² represents a straight chain or branched alkyl group having from 1 to 4 carbon atoms; and X represents a halogen atom, to obtain said optically active 4-halo-1,3-butanediol represented by the formula (IV). A process as claimed in any preceding claim, wherein R¹ is a methyl or isobutyl group. A process as claimed in any preceding claim, wherein the benzylamine derivative (II) is added in an amount of 1 to 2 moles per mole of the compound (I) and the mixture is heated at reflux for 5 to 20 hours.

Inventors: KUMOBAYASHI HIDENORI C O TAKAS, OKEDA YOSHIKI C O TAKASAGO RES, SEIDO NOBUO C O TAKASAGO RES I, KUMOBAYASHI, HIDENORI, C/O TAKASAGO RES. INST. INC, OKEDA, YOSHIKI, C/O TAKASAGO RES. INST. INC., SEIDO, NOBUO, C/O TAKASAGO RES. INST. INC.
Applicants: TAKASAGO PERFUMERY CO LTD, TAKASAGO INTERNATIONAL CORPORATION
Application year: 1991
Main classification: C07D207
IPC codes: C07D207, C07C309, C07C31, C07C211, C07B53